Cellbricks Revenue and Competitors

Berlin, Germany

Location

N/A

Total Funding

3D

Industry

Estimated Revenue & Valuation

  • Cellbricks's estimated annual revenue is currently $2.7M per year.(i)
  • Cellbricks's estimated revenue per employee is $119,000

Employee Data

  • Cellbricks has 23 Employees.(i)
  • Cellbricks grew their employee count by 5% last year.

Cellbricks's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.7M235%N/AN/A
#2
$1.7M17-15%N/AN/A
#3
$23.1M13613%N/AN/A
#4
$17.7M104-25%N/AN/A
#5
$2.9M240%N/AN/A
#6
$8M5227%N/AN/A
#7
$13.4M7923%N/AN/A
#8
$4.1M30-17%N/AN/A
#9
$26.9M14419%N/AN/A
#10
$2.9M2420%N/AN/A
Add Company

What Is Cellbricks?

Cellbricks developed a new Bioprinting technology, which allows creating complex three-dimensional structures made of biological material. We are specialized in Bioprinting services, creating customized as well as off the shelf products. The company produces organ-models, living 3D cell cultures and scaffolds. Cellbricks empowers researchers to investigate functional human tissues for fundamental biological research or advanced regenerative therapies. Within 2016 Cellbricks established its technology and created its first Mini-Organs finding application in state of the art tissue engineering. The company won notable institutes and companies as pilot customers for individual projects. The team has won numerous awards for its innovative technology.

keywords:N/A

N/A

Total Funding

23

Number of Employees

$2.7M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cellbricks News

2022-04-20 - CollPlant CEO Yehiel Tal to Moderate ISBF's virtual event on Biofabrication of Microphysiological Systems for Drug Discovery and Screening

... Dr. Ben Maoz from Tel Aviv University, Dr. Lutz Kloke, founder and CSO of Cellbricks and Dr. Jeroen Eyckmans from Boston University.

2022-04-17 - Rápido crecimiento del mercado de órganos impresos en 3D ...

Rápido crecimiento del mercado de órganos impresos en 3D | Empresas clave: Poietis, Cellbricks, nScrypt | Previsiones hasta 2029...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.3M2310%N/A
#2
$2.3M23N/AN/A
#3
$2.1M23N/AN/A
#4
$3.5M23-12%N/A
#5
$4M23-21%N/A